Tarsus Pharmaceuticals, Inc. ($TARS)
Filing Information
| Accession Number | 0001827584-26-000009 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 19, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
11,324
Total Value
$772,443.60
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Mar 17, 2026 | Sale | 3,125 | $69.42 | $216,937.50 | 93,979 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 18, 2026 | Sale | 3,610 | $68.71 | $248,043.10 | 90,369 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 19, 2026 | Sale | 4,589 | $67.00 | $307,463.00 | 85,780 | Direct | โ | View Details |